[Novel immunosuppressive drugs in renal transplantation].
The major targets of novel immunosuppressive protocols are decreased toxicity and improved graft and patient survival. Over the last decade, several drugs have been demonstrated to have potential beneficial effect in transplantation. Most of these agents are currently in phase II or III of clinical studies.